Books > Professional & Technical > Industrial chemistry & manufacturing technologies > Industrial chemistry > Pharmaceutical technology
|
Buy Now
Bioequivalence Requirements in Various Global Jurisdictions (Hardcover, 1st ed. 2017)
Loot Price: R6,470
Discovery Miles 64 700
|
|
Bioequivalence Requirements in Various Global Jurisdictions (Hardcover, 1st ed. 2017)
Series: AAPS Advances in the Pharmaceutical Sciences Series, 28
Expected to ship within 12 - 17 working days
|
Although the Bioequivalence (BE) requirements in many global
jurisdictions have much in common, differences in certain
approaches and requirements such as definitions and terms, choice
of comparator (reference) product, acceptance criteria, fasted and
fed studies, single and multi-dose studies, biowaivers and products
not intended for absorption into the systemic circulation (locally
acting medicines and dosage forms), amongst others, provide food
for thought that standardisation should be a high priority
objective in order to result in a harmonized international process
for the market approval of products using BE. An important
objective of Bioequivalence Requirements in Various Global
Jurisdictions is to attempt to gather the various BE requirements
used in different global jurisdictions to provide a single source
of relevant information. This information from, Brazil, Canada,
China, European Union, India, Japan, MENA, Russia South Africa, the
USA and WHO will be of value to drug manufacturers, regulatory
agencies, pharmaceutical scientists and related health
organizations and governments around the world in the quest to
harmonize regulatory requirements for the market approval of
generic products.
General
Is the information for this product incomplete, wrong or inappropriate?
Let us know about it.
Does this product have an incorrect or missing image?
Send us a new image.
Is this product missing categories?
Add more categories.
Review This Product
No reviews yet - be the first to create one!
|
|
Email address subscribed successfully.
A activation email has been sent to you.
Please click the link in that email to activate your subscription.